Document Detail


Strong expression of CD133 is associated with increased cholangiocarcinoma progression.
MedLine Citation:
PMID:  21448425     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To determine the role of CD133 in cholangiocarcinoma progression.
METHODS: CD133 protein expression was evaluated by immunohistochemistry in 34 cholangiocarcinoma specimens. In addition, proliferation, chemoresistance and invasive properties of CD133-enriched (CD133(+)) and CD133-depleted (CD133(-)) RMCCA1 cholangiocarcinoma cells were studied and compared.
RESULTS: Strong CD133 expression was observed in 67.6% (23/34) of the cholangiocarcinoma specimens. Strong expression of CD133 was significantly associated with nodal metastasis (P = 0.009) and positive surgical margin status (P = 0.011). In the in vitro study, both the CD133(+) and CD133(-) cells had similar proliferation abilities and resistance to chemotherapeutic drugs. However, the CD133(+) cells had a higher invasive ability compared with CD133(-) cells.
CONCLUSION: CD133+ cells play an important role in the invasiveness of cholangiocarcinoma. Targeting of the CD133+ cells may be a useful approach to improve treatment against cholangiocarcinoma.
Authors:
Kawin Leelawat; Taweesak Thongtawee; Siriluck Narong; Somboon Subwongcharoen; Sa-ad Treepongkaruna
Related Documents :
321125 - Ontogeny of rat pancreatic polypeptide (pp) cells.
6777225 - Cytotoxic activation of complement by mouse pancreatic islet cells.
1373745 - Analysis of islet cell antibodies reactivity to a human islet cell line.
759245 - Regional distribution and concentration of pancreatic polypeptide in the human and cani...
22905165 - The integrity of the cytokinesis machinery under stress conditions requires the glucan ...
18846285 - Spectroscopic properties and bacteriochlorophyll c isomer composition of extramembranou...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  17     ISSN:  2219-2840     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-30     Completed Date:  2011-07-18     Revised Date:  2014-05-20    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  1192-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD / immunology*
Bile Duct Neoplasms / immunology*,  pathology*
Bile Ducts, Intrahepatic / pathology*
Cell Proliferation
Cholangiocarcinoma / immunology*,  pathology*
Disease Progression*
Drug Resistance, Neoplasm
Glycoproteins / immunology*
Humans
Middle Aged
Neoplasm Invasiveness
Peptides / immunology*
Survival Rate
Chemical
Reg. No./Substance:
0/AC133 antigen; 0/Antigens, CD; 0/Glycoproteins; 0/Peptides
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromi...
Next Document:  Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan.